EUS-FNA for Patients With Antithrombotic Agents
Safety of Endoscopic Ultrasound-guided Fine Needle Aspiration for Patients With Antithrombotic Agents
1 other identifier
observational
84
1 country
1
Brief Summary
The purpose of this study to evaluate a safety of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for patients with antithrombotic agents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 22, 2013
CompletedFirst Posted
Study publicly available on registry
February 26, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedFebruary 19, 2016
February 1, 2016
3 years
February 22, 2013
February 18, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Patients who suffered bleeding complication
One week
Study Arms (1)
Antithrombotic agents
Eligibility Criteria
In hospital
You may qualify if:
- Undergo EUS-FNA
- take antithrombotic agents
You may not qualify if:
- Cystic lesion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hokkaido University Graduate School of Medicine
Sapporo, 0808648, Japan
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D. and Ph.D.
Study Record Dates
First Submitted
February 22, 2013
First Posted
February 26, 2013
Study Start
September 1, 2012
Primary Completion
September 1, 2015
Last Updated
February 19, 2016
Record last verified: 2016-02